xyzmo SIGNificant Suite is Now Certified Compliant With SAFE-BioPharma Digital Standard

Jersey City, November 17, 2008 – xyzmo SIGNificant Group, the leading international digital and e-signature technology provider, announced today that its product, SIGNificant Suite, has been certified to be compliant with the SAFE-BioPharma™ digital identity and signature standard.

“By making its SIGNificant Suite compliant with the SAFE-BioPharma standard, xyzmo has made a unique and therefore very attractive product available to the pharmaceutical industry. We encourage our member companies to take a close look at this three-level authentication-enabled signature technology” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.

Read more..